Skip to main content
Premium Trial:

Request an Annual Quote

Genomics One Lists 20M Shares on Montreal Exch.

Premium

LAVAL, Quebec--Genomics One, developer of technology platforms for genomic manipulations and gene discovery here, announced last month that it listed 19.7 million common shares and 3 million warrants at the Montreal Exchange. The company, which was incorporated in 1995, said its technologies have applications for research, therapeutics, diagnostics, and industrial processes.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.